Cholesterol-lowering Effect of Protein Hydrolysates from Lemongrass (Cymbopogon citratus Stapf.)

Author:

Villalobos Mizpah C.1ORCID,Nicolas Marilou G.2ORCID,Trinidad Trinidad P.3ORCID

Affiliation:

1. 1Chemistry Department, Central Philippine University Iloilo City Philippines.

2. 3Department of Physical Sciences and Mathematics, University of the Philippines Manila.

3. 2The Graduate School, University of Santo Tomas España Manila.

Abstract

Lemongrass (Cymbopogon citratus Stapf.) has been used in the Philippines for cooking and as an herb to treat a variety of ailments including hypertension and related cardiovascular diseases (CVDs). This study determined the potential of peptides obtained from the hydrolysis of lemongrass proteins to lower cholesterol in vitro and in an animal model. Proteins were extracted and digested in vitro simulating gastrointestinal conditions. Protein hydrolysates were collected and fractionated using RP-SPE column, and assayed for HMG-CoA reductase inhibitory activity against pravastatin as a control drug. Tannin-free protein extract (TFPE) and total protein hydrolysates (TPC) were administered to Sprague-Dawley rats maintained on a high-fat high-cholesterol diet for two weeks. TFPE yield was 0.03%. Simulated gastrointestinal digestion of the TFPE resulted in 74% yield of protein hydrolysates. Three fractions were obtained from RP-SPE elution of the protein hydrolysates, each with potent HMG-CoA inhibitory activity. The F3 fraction had the highest inhibition of HMG-CoA reductase (IC50 = 0.76 ppm, comparable to pravastatin (IC50 = 0.25 ppm). The inhibitory activity of the fractions was further confirmed through significant serum cholesterol reduction (p < 0.05) in Sprague-Dawley rats. Thus, protein hydrolysates from lemongrass have potential cholesterol-lowering effects in vitro through HMG-CoA reductase inhibition and in vivo through significant reduction of cholesterol levels in an animal model. Protein hydrolysates from lemongrass dietary proteins may serve as promising functional foods for the prevention of CVD risk.

Publisher

Enviro Research Publishers

Subject

Medicine (miscellaneous),Food Science

Reference49 articles.

1. 1. Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risk factors: 2020 and beyond. J Am Coll Cardiol 2019;74(20):2529–2532; doi: 10.1016/j.jacc.2019.10.009.

2. 2. Masic I, Alajbegovic J. The significance of the psychosocial factors influence in pathogenesis of cardiovascular disease. Int J Prev Med 2013;4(11):1223–1230.

3. 3. Rudd JHF, Davies JR, Weissberg PL. Atherosclerotic biology and epidemiology of disease. In: Topol EJ, Califf RM, Prystowsky EN, Thomas JD, Thompson PD, editors. Textbook of Cardiovascular Medicine. 3rd ed. Philadelphia, PA 19106: Lippincott Williams & Wilkins; 2007. p. 2–12.

4. 4. McNamara DJ. Cholesterol: Sources, absorption, function and metabolism Factors Determining Blood Levels. In: Encyclopedia of Human Nutrition. 2nd ed. Elsevier Ltd.; 2005. p. 379–385.

5. 5. Burg JS, Espenshade PJ. Regulation of HMG-CoA reductase in mammals and yeast. Prog Lipid Res 2011; 50(4):403–410; doi: 10.1016/j.plipres.2011.07.002.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3